Relationships of Atrial Fibrillation at Diagnosis and Type of Atrial Fibrillation During Follow-up With Long-Term Outcomes for Heart Failure With Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Relationships of Atrial Fibrillation at Diagnosis and Type of Atrial Fibrillation During Follow-up With Long-Term Outcomes for Heart Failure With Preserved Ejection Fraction

Published:2022-06-10 Issue:6 Volume:4 Page:255-263
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Nakatani Daisaku¹,Dohi Tomoharu¹,Takeda Toshihiro²,Okada Katsuki¹,Sunaga Akihiro¹,Oeun Bolrathanak¹,Kida Hirota¹,Sotomi Yohei¹,Sato Taiki¹,Kitamura Tetsuhisa³,Suna Shinichiro¹,Mizuno Hiroya¹,Hikoso Shungo¹,Matsumura Yasushi⁴,Sakata Yasushi¹

Affiliation:

1. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine

2. Department of Medical Informatics, Osaka University Graduate School of Medicine

3. Department of Environmental Medicine and Population Sciences, Osaka University Graduate School of Medicine

4. Osaka National Hospital

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/4/6/4_CR-22-0006/_pdf

Reference29 articles.

1. 1. Kotecha D, Lam CS, Van Veldhuisen DJ, Van Gelder IC, Voors AA, Rienstra M. Heart failure with preserved ejection fraction and atrial fibrillation: Vicious twins. J Am Coll Cardiol 2016; 68: 2217–2228.

2. 2. Kitaoka H, Tsutsui H, Kubo T, Ide T, Chikamori T, Fukuda K, et al. JCS/JHFS 2018 guideline on the diagnosis and treatment of cardiomyopathies. Circ J 2021; 85: 1590–1689.

3. 3. Vellinga A, Cormican M, Hanahoe B, Bennett K, Murphy AW. Opt-out as an acceptable method of obtaining consent in medical research: A short report. BMC Med Res Methodol 2011; 11: 40.

4. 4. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998; 32: 695–703.

5. 5. Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 2006; 47: 1997–2004.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive nomogram for postoperative atrial fibrillation in locally advanced esophageal squamous carcinoma cell with neoadjuvant treatment;Frontiers in Surgery;2023-01-04